Ortho Development announced it has received clearance from the U.S. Food and Drug Administration for KASM Knee Articulating Spacer Molds.
KASM is a cement spacer mold intended for use in treating patients who develop an infection after undergoing total knee replacement surgery.
E. Marc Mariani, MD, and Michael H. Bourne, MD, from the Salt Lake Orthopaedic Clinic in Salt Lake City, Utah assisted Ortho Development's engineers with the development of KASM.
Ortho Development is a company that designs, manufactures and markets devices for knee and hip joint reconstruction, spine treatment and trauma.
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws